Pfizer Complete Financial Statements
PFIZER • Review detailed financials to uncover trends, confirm thesis & journal trades
11 Years of Data
2025 - 2015
Complete Financial Data Export
Export complete financial statements for Pfizer (PFIZER).
Downloads include all available records across all periods.
Profitability Ratios
Net Profit Margin
31.30%
2025 data
EBITDA Margin
37.20%
2025 data
Operating Margin
32.00%
2025 data
Return on Assets
15.64%
2025 data
Return on Equity
18.21%
2025 data
Balance Sheet Ratios
Current Ratio
28.33
2025 data
Equity Ratio
85.87%
2025 data
Asset Turnover
0.50
2025 data
Year-over-Year Growth Analysis
Comparing March 2025 vs Period
Revenue Growth
+16.0%
Year-over-Year
Net Profit Growth
+11.2%
Year-over-Year
EBITDA Growth
+31.7%
Year-over-Year
Expense Growth
+6.7%
Year-over-Year
Assets Growth
+16.1%
Year-over-Year
Equity Growth
+17.3%
Year-over-Year
Operating Cash Flow Growth
+156.8%
Year-over-Year
Investing Cash Flow Growth
-231.5%
Year-over-Year
Financing Cash Flow Growth
+12.8%
Year-over-Year
Income Statement
Periods
₹ Crores
| Particulars | None | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2,847 | 2,454 | 2,374 | 2,526 | 2,674 | 2,320 | 2,336 | 2,249 | 2,083 | 2,067 | 2,103 | 1,921 |
| Expenses | 1,645 | 1,541 | 1,558 | 1,616 | 1,775 | 1,526 | 1,579 | 1,516 | 1,468 | 1,617 | 1,586 | 1,470 |
| EBITDA | 1,202 | 913 | 816 | 910 | 898 | 793 | 757 | 733 | 615 | 450 | 517 | 450 |
| Operating Profit Margin % | 34.00% | 32.00% | 29.00% | 33.00% | 32.00% | 32.00% | 27.00% | 27.00% | 25.00% | 18.00% | 21.00% | 21.00% |
| Depreciation | 59 | 61 | 62 | 106 | 115 | 109 | 103 | 71 | 66 | 63 | 124 | 131 |
| Interest | 10 | 8 | 15 | 13 | 11 | 15 | 11 | 1 | 0 | 1 | 1 | 1 |
| Profit Before Tax | 1,133 | 1,016 | 746 | 824 | 773 | 669 | 643 | 660 | 548 | 517 | 402 | 238 |
| Tax | 290 | 249 | 195 | 200 | 160 | 171 | 133 | 231 | 188 | 180 | 179 | 138 |
| Net Profit | 854 | 768 | 551 | 624 | 613 | 498 | 509 | 429 | 360 | 337 | 223 | 100 |
| Earnings Per Share (₹) | 186.60 | 136.46 | 119.22 | 136.38 | 133.89 | 108.77 | 111.28 | 93.78 | 78.70 | 73.61 | 66.66 | 15.26 |
Related Pages for Pfizer
Additional stock information and data for PFIZER
Balance Sheet
Years
Annual Data
₹ Crores
| Particulars | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||
| Total Assets | 4,911 | 4,229 | 4,001 | 3,901 | 3,266 | 4,405 | 3,940 | 3,690 | 3,261 | 2,914 | 2,612 |
| Current Assets | 3,513 | 2,738 | 2,525 | 2,397 | 1,925 | 3,048 | 2,715 | 2,417 | 2,051 | 1,630 | 1,253 |
| Fixed Assets | 724 | 713 | 749 | 869 | 894 | 973 | 886 | 950 | 902 | 895 | 944 |
| Capital Work in Progress | 8 | 0 | 8 | 1 | 3 | 1 | 0 | 1 | 15 | 3 | 13 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4 | 0 |
| Other Assets | 4,180 | 3,516 | 3,244 | 3,030 | 2,369 | 3,432 | 3,054 | 2,739 | 2,343 | 2,011 | 1,655 |
| LIABILITIES | |||||||||||
| Total Liabilities | |||||||||||
| Current Liabilities | 124 | 87 | 136 | 183 | 99 | 137 | 37 | 52 | 62 | 36 | 32 |
| Non-Current Liabilities | |||||||||||
| SHAREHOLDERS' EQUITY | |||||||||||
| Total Equity | 4,217 | 3,596 | 3,207 | 2,864 | 2,393 | 3,396 | 3,011 | 2,683 | 2,419 | 2,118 | 1,973 |
| Share Capital | 46 | 46 | 46 | 46 | 46 | 46 | 46 | 46 | 46 | 46 | 46 |
| Reserves & Surplus | 4,172 | 3,550 | 3,162 | 2,819 | 2,347 | 3,350 | 2,966 | 2,637 | 2,373 | 2,072 | 1,927 |
Cash Flow Statement
Periods
₹ Crores
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 660 | 257 | 356 | 667 | 427 | 323 | 98 | 332 | 329 | 346 | 114 |
| Investing Activities | -71 | 54 | -36 | -575 | -469 | 1,530 | 35 | -238 | -250 | -701 | 68 |
| Financing Activities | -205 | -235 | -346 | -181 | -1,571 | -164 | -110 | -110 | -83 | -62 | -1 |
| Net Cash Flow | 383 | 75 | -26 | -88 | -1,613 | 1,690 | 23 | -17 | -4 | -417 | 181 |